Associate Director for Education and Training, Rogel Cancer Center
Associate Professor, Departments of Pediatrics and Pathology
University of Michigan
Ann Arbor, Mich.
Elizabeth R. Lawlor, M.D., Ph.D., completed her clinical training in Pediatrics and Pediatric Hematology-Oncology in Canada before embarking on post-doctoral research training at the University of California, San Francisco. She began her independent lab at Children’s Hospital Los Angeles and, since 2010, she has been at the University of Michigan in Ann Arbor. The central hypothesis underlying Dr. Lawlor’s research is that pediatric cancers, in particular Ewing sarcoma, stem from hijacked regulation of developmental programs that are intrinsic to normal embryogenesis. The overall goal of her lab is to discover and define differences between normal and cancer cell biology in order to enable development of targeted therapeutics. To achieve this her lab uses diverse cell and animal models, and collaborates actively with experts in developmental biology, epigenetics, metabolism, and drug development. As a dual-trained M.D. and Ph.D. physician-scientist, Dr. Lawlor is committed to educating the next generation of basic and translational researchers and is dedicated to graduate and post-graduate education in the areas of cancer biology and pediatric oncology. She is the director of the Ph.D. graduate program in Cancer Biology and the Associate Director for Education at the University of Michigan Rogel Cancer Center.